Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products!
Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
FUN-N52H3 | Nipah virus | Nipah virus Pre-Fusion glycoprotein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Loaded Anti-Fusion Protein Antibody, Human IgG1 (5B3) on AHC Biosensor, can bind Nipah virus Pre-Fusion glycoprotein, His Tag (Cat. No. FUN-N52H3) with an affinity constant of 8.4 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
The purity of Nipah virus Pre-Fusion glycoprotein, His Tag (Cat. No. FUN-N52H3) is more than 90% and the molecular weight of this protein is around 170-200 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Nirsevimab | SP-0232; MEDI-8897; Anti-RSV MAb-YTE; Anti-RSV-mAb-D25 | Approved | Aimm Therapeutics, Sanofi, MedImmune Inc | Beyfortus | EU | Respiratory Syncytial Virus Infections | Astrazeneca Ab | 2022-10-31 | Lower Respiratory Tract Infections; Respiratory Syncytial Virus Infections | Details |
Palivizumab | ABT-315; MEDI-493 | Approved | Abbvie Inc, Medimmune Llc | Synagis | United States | Respiratory Syncytial Virus Infections | Swedish Orphan Biovitrum Ab (Publ) | 1998-06-19 | Bronchopulmonary Dysplasia; Respiratory Syncytial Virus Infections; Infant, Premature, Diseases; Heart Defects, Congenital; Premature Birth | Details |
Respiratory syncytial virus immune globulin | RSV-IGIV | Approved | Medimmune | RespiGam | United States | Respiratory Syncytial Virus Infections | null | 1996-01-01 | Respiratory Syncytial Virus Infections | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
CPI-RSV-F Vaccine | BLB-201 | Phase 2 Clinical | Blue Lake Biotechnology Inc | Respiratory Syncytial Virus Infections | Details |
GR-2102 | GR2102; GR-2102 | Phase 1 Clinical | Genrix (Shanghai) Biopharmaceutical Co Ltd, Chongqing Zhixiang Jintai Biopharmaceutical Co Ltd | Respiratory Syncytial Virus Infections | Details |
Palivizumab biosimilar (mAbxience) | Phase 1 Clinical | Mabxience Sa | Details |
This web search service is supported by Google Inc.